Sildenafil
NDC 0591-4050, Sildenafil, powder, for suspension, from Actavis Pharma, Inc..
- Product NDC
- 0591-4050
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211534
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0591-4050 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SILDENAFIL CITRATE10 mg/mL
Pharmacologic classes
Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0591-4050-94 | 00591405094 | 1 BOTTLE in 1 CARTON (0591-4050-94) / 112 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0e6428c0-e0e9-4fc0-8615-6a9678d2286cNADAC price for package 00591405094
GET /v1/drugs/nadac/00591405094
Use it
Look up 0591-4050 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0591-4050 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0591-4050. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.